AI-Powered Blood Test Enhances Early Detection of Ovarian Cancer
An AI-powered blood test combining DNA fragment analysis with protein biomarkers significantly improves early ovarian cancer detection.
Read MorePosted by Andy Lundin | Sep 30, 2024 | Molecular Diagnostics, Unknown Origin & Other Cancer Types |
An AI-powered blood test combining DNA fragment analysis with protein biomarkers significantly improves early ovarian cancer detection.
Read MorePosted by Andy Lundin | Sep 23, 2024 | Cancer |
Dancer diagnoses in the U.S. remained below pre-pandemic levels in 2021, with fewer early-stage and late-stage diagnoses compared to 2020.
Read MorePosted by Andy Lundin | Sep 17, 2024 | Digital Pathology |
Roche’s navify digital pathology enterprise software now integrates a range of AI-driven algorithms, enabling enhanced cancer diagnostics.
Read MorePosted by Andy Lundin | Sep 13, 2024 | Cardiovascular |
A new review finds that 20% of the global population carries a genetic risk for cardiovascular diseases due to high levels of lipoprotein(a).
Read MorePosted by Andy Lundin | Sep 11, 2024 | Digital Pathology, Lung Cancer |
The MET Predict assists in identifying NSCLC tumors with MET exon 14 skipping or MET amplification directly from H&E whole slide images.
Read More